Sri Mudumba

Sri Mudumba has a wide range of work experience in the pharmaceutical and biotechnology industry. Currently, they serve as the Chief Research & Development Officer at PYC Therapeutics. Prior to this, they held various leadership roles at Santen, including Vice President, Retina Franchise Lead & Global Pharmaceutical Development, Senior Director & Head of Pharmaceutical Development, and VP, Modality Innovation. Sri also worked as a Scientist in Drug Delivery at Genentech, Inc. They have also held positions at MacuSight, Inc., Corium International Inc., PowderJect Technologies, Inc., Cygnus Inc., UCSF, Dr. Howard Maibach's Lab, ALZA Corporation, and Neurex Corporation.

Sri Mudumba obtained a PhD in Pharmaceutical Sciences from the University of the Pacific, where they studied from 1991 to 1997. Prior to that, Sri Mudumba completed an M.Pharm in Pharmacology from Jadavpur University and a B.Pharm in Pharmacy from Kakatiya University. However, the specific start and end years for the latter two degrees are not provided.